Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov:83:130-134.
doi: 10.1016/j.neurobiolaging.2019.04.016.

What are the threats to successful brain and cognitive aging?

Michela Gallagher  1 , Ozioma C Okonkwo  2 , Susan M Resnick  3 , William J Jagust  4 , Tammie L S Benzinger  5 , Peter R Rapp  6
Affiliations

What are the threats to successful brain and cognitive aging?

Michela Gallagher et al. Neurobiol Aging. 2019 Nov.

Abstract

The structure and function of the brain change over the life span. Aged brains often accumulate pathologic lesions, such as amyloid plaques and tau tangles, which lead to diminished cognitive ability in some, but not all, individuals. The basis of this vulnerability and resilience is unclear. Age-related changes can alter neural firing patterns and ability to form new memories. Risk factors for cognitive decline include male sex and apolipoprotein E genotype. Physical activity seems to be protective against cognitive decline. Longitudinal studies have shown that, although the onset of amyloid pathology and associated cognitive decline can vary greatly, once it begins, the rate of deposition is similar among affected individuals. This session of the Cognitive Aging Summit III explored fixed and modifiable factors that can threaten cognitive function in aging adults and approaches to modulate at least some of these risks.

Keywords: Compensation; Maintenance; Modifiable factors; Pathology; Reserve; Resilience.

PubMed Disclaimer

References

    1. Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 2012;74:467–74. doi: 10.1016/j.neuron.2012.03.023. - DOI - PMC - PubMed
    1. Bakker A, Albert MS, Krauss G, Speck CL, Gallagher M. Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance. Neuroimage Clin 2015;7:688–98. doi: 10.1016/j.nicl.2015.02.009 - DOI - PMC - PubMed
    1. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J of Med 2012;367(9):795–804. doi: 10.1056/NEJMoa1202753. - DOI - PMC - PubMed
    1. Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ. Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease. Proc Natl Acad Sci 2013;110(47):E4502–9. doi: 10.1073/pnas.1317918110. - DOI - PMC - PubMed
    1. Bilgel M, Prince JL, Wong DF, Resnick SM, Jedynak BM. A multivariate nonlinear mixed effects model for longitudinal image analysis: application to amyloid imaging. Neuroimage 2016;134:658–70. doi: 10.1016/j.neuroimage.2016.04.001. - DOI - PMC - PubMed

Publication types